DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Vertex Pharmaceuticals

Vertex Pharmaceuticals

  • Telaprevir (Incivek)

    Telaprevir (Incivek)

  • ARK GENOMIC REVOLUTION MULTI SECTOR ETF (ARKG) HOLDINGS As of 09/27/2021

    ARK GENOMIC REVOLUTION MULTI SECTOR ETF (ARKG) HOLDINGS As of 09/27/2021

  • Vertex Pharmaceuticals Global Medical Affairs Pharmd Fellowship Program 2020 Message from Global Medical Affairs Leadership

    Vertex Pharmaceuticals Global Medical Affairs Pharmd Fellowship Program 2020 Message from Global Medical Affairs Leadership

  • United States Securities and Exchange Commission Form

    United States Securities and Exchange Commission Form

  • Pax Large Cap Fund USD 7/31/2021 Port

    Pax Large Cap Fund USD 7/31/2021 Port

  • PD2M Newsletter

    PD2M Newsletter

  • Vertex Pharmaceuticals Announces That VX-680 Demonstrates Effect on Clinically Relevant Biomarker in Phase I Cancer Study

    Vertex Pharmaceuticals Announces That VX-680 Demonstrates Effect on Clinically Relevant Biomarker in Phase I Cancer Study

  • Rare Diseases Whitepaper

    Rare Diseases Whitepaper

  • Declarations of Interest Thorax: First Published As 10.1136/Thoraxjnl-2016-209333.464 on 15 November 2016

    Declarations of Interest Thorax: First Published As 10.1136/Thoraxjnl-2016-209333.464 on 15 November 2016

  • Moderna Therapeutics Named the No. 3 Top Employer by Science Magazine

    Moderna Therapeutics Named the No. 3 Top Employer by Science Magazine

  • VERTEX PHARMACEUTICALS INCORPORATED (Name of Registrant As Specified in Its Charter)

    VERTEX PHARMACEUTICALS INCORPORATED (Name of Registrant As Specified in Its Charter)

  • Merck & Co., Inc. and Vertex Announce

    Merck & Co., Inc. and Vertex Announce

  • Janssen Pharmaceutica Announces Collaboration with Vertex Pharmaceuticals to Develop and Commercialize VX-950 for Treatment of Hepatitis C

    Janssen Pharmaceutica Announces Collaboration with Vertex Pharmaceuticals to Develop and Commercialize VX-950 for Treatment of Hepatitis C

  • Integrating Iot and Smart Pharma Technology To

    Integrating Iot and Smart Pharma Technology To

  • Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop Mrna Therapeutics™ for Cystic Fibrosis

    Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop Mrna Therapeutics™ for Cystic Fibrosis

  • Vertex Pharmaceuticals Incorporated

    Vertex Pharmaceuticals Incorporated

  • Vertex Pharmaceuticals Incorporated

    Vertex Pharmaceuticals Incorporated

  • Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)

    Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)

Top View
  • Vertex's Collaborator Merck Suspends Patient Enrollment in Clinical Trials of MK-0457 (VX- 680) Pending Full Analysis of Clinical Data
  • Use of Real-World Evidence Expands to Transform Drug Development
  • Regeneron Pharmaceuticals Inc
  • A 1-Year Smartphone Study in Multiple Sclerosis
  • 5.15 Attendee List As of 5.10.Xlsx
  • MED-Project Participating Drug Companies - King County Washington, March 2020
  • TF Rarediseases FEB15.Indd
  • 02/04/2016 Provider Subsystem Healthcare and Family Services Run Time: 20:10:22 Report Id 2794D051 Page: 01
  • The Dawn of a New Era: Transforming Our Domestic Response to Hepatitis B & C
  • Vertex Appoints Diana Mckenzie to Its Board of Directors
  • Portfolio of Investments
  • CFRI's Weekly Summary of News & Events for Our CF Community!
  • Drug Metabolism Discussion Group
  • VERTEX PHARMACEUTICALS INCORPORATED (Name of Registrant As Specified in Its Charter)
  • Vertex Pharmaceuticals Incorporated (VRTX) Item 7 Friends Fiduciary Corporation Friends Fiduciary Corporation Seeks Your Support
  • 2011 Iq Symposium Cambridge, Massachusetts Marriott Cambridge
  • Industry Work on Rare Diseases Continues to Bear Fruit
  • Third Quarter Report (PDF)


© 2024 Docslib.org    Feedback